Malignant fungating wounds assessment in palliative care: a scoping review.

INTRODUCTION

Malignant fungating wounds (MFWs) are secondary chronic wounds resulting from malignant cell proliferation and migration, compromising skin integrity in patients with cancer. These wounds present a range of signs and symptoms. Although several instruments are used in their assessment, it is still unclear which tool is most appropriate for comprehensive evaluation and wound healing.

AIM: To review the existing instruments for MFW assessment, highlighting their strengths and limitations.

METHODS

A scoping review was conducted following the Arksey and O'Malley framework (2005), the Joanna Briggs Institute guidelines (2020, 2021), and the PRISMA-ScR checklist (2018). The search was performed on four databases: Web of Science, Scopus, PubMed, and EBSCO.

RESULTS

Forty studies were included, describing 22 instruments. They described half targeted general symptoms, and half wound-related signs and symptoms. Four instruments were specifically designed for MFWs, all based on the Malignant Wound Assessment Tool (MWAT). These were: MWAT - Clinical; MWAT- wound bed status; MWAT- Perception; MWAT - Research. However, only the Clinical and Research versions were validated in English, but neither was subjected to psychometric validation, and lacked a comprehensive assessment, such as key symptoms.

CONCLUSION

Despite the existence of specific tools for MFW assessment, a comprehensive, validated, and standardized tool is still lacking. While the Clinical and the Research versions of the MWAT offer a broad assessment of MFWs, they require refinement to address overlooked symptoms and validation in other languages. Establishing standardized, multidimensional measures could enhance clinical decision-making and improve outcomes for patients living with MFWs.